✦ LIBER ✦

Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes

✍ Scribed by Nigel Stallard; Peter F. Thall; John Whitehead

Book ID: 110724620
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 812 KB
Volume: 55
Category: Article
ISSN: 0006-341X
DOI: 10.1111/j.0006-341x.1999.00971.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decision-Theoretic Designs for Phase II

Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies

✍ Nigel Stallard 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Decision-Theoretic Designs for Pre-Phase

Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology

✍ Nigel Stallard; Peter F. Thall 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 755 KB

Bayesian decision theoretic two-stage de

Bayesian decision theoretic two-stage design in phase II clinical trials with survival endpoint

✍ Lili Zhao; Jeremy M.G. Taylor; Scott M. Schuetze 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

Balanced two-stage designs for phase II

Balanced two-stage designs for phase II clinical trials

✍ Fei Ye, ; Shyr, Y. 📂 Article 📅 2007 🏛 SAGE Publications 🌐 English ⚖ 156 KB

Optimal three-stage designs for phase II

Optimal three-stage designs for phase II cancer clinical trials

✍ T. Timothy Chen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

The objective of a phase II cancer clinical trial is to screen a treatment that can produce a similar or better response rate compared to the current treatment results. This screening is usually carried out in two stages as proposed by Simon. For ineffective treatment, the trial should terminate at

Designs for Phase I Clinical Trials with

Designs for Phase I Clinical Trials with Multiple Courses of Subjects at Different Doses

✍ Shenghua K Fan; You-Gan Wang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB